Remote Symptom Review in Patients With Implantable Diagnostic Holter
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
To study the clinical and organizational benefit of implementing a methodology for monitoring patients receiving an implantable diagnostic BIOMONITOR III holter and successive models, consisting of remote review of alerts sent by the device via the HOME MONITORING remote monitoring platform and the transmission of relevant patient symptoms through the use of a specific application installable on the patient's phone. The efficiency of this methodology will be compared with a control group consisting of monitoring through the usual clinical practice of the hospital.
Eligibility Criteria
Inclusion Criteria: * Patients indicated for implantation of a subcutaneous implantable holter due to syncope or cryptogenic stroke (atrial fibrillation detection) * Patients over 18 years old. * Patients who consent to the installation of a patient application for telematic submission of patient-related symptoms. * Patients capable of using the patient application. Exclusion Criteria: * Patients over 80 years of age or, failing that, not able to use an application to send their symptoms. * Life expectancy of less than 12 months for any reason.